
TB-500 5mg Spray (Thymosin Beta-4 analog) is a research-grade synthetic peptide formulated in a pre-metered liquid vehicle for non-invasive laboratory research. Mimicking endogenous Thymosin Beta-4, TB-500 (sequence: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH) acts as a primary actin-sequestering peptide, binding monomeric G-actin in a 1:1 ratio. Formulated as a stabilized solution at a strength of 5mg, each bottle supports reproducible tissue repair and angiogenesis investigations.
HPLC certified
Independent analysis
Highest standard
Full traceability
TB-500 5mg Spray is a synthetic 43-amino-acid peptide solution designed to evaluate non-invasive mucosal transport kinetics and actin-sequestering cytoskeletal remodeling. Functioning as a Thymosin Beta-4 analog, TB-500 binds globular actin (G-actin) to prevent its polymerization into filamentous actin (F-actin), promoting cell migration, endothelial tube formation (angiogenesis), and wound remodeling. Unlike standard lyophilized powders that require reconstitution, this spray format provides a concentration-verified, pre-dissolved liquid format calibrated for precise laboratory assays.
Researchers continue to investigate TB-500 across major areas of regenerative biology, including cardiac tissue repair, muscle injury recovery models, corneal healing, and dermal tissue regeneration. The liquid spray formulation is of high scientific interest because it allows researchers to study epithelial membrane transport kinetics of larger peptides and tight junction interactions in mucosal or local tissue layers without invasive administration. Formulated with high-purity research-grade materials and verified by HPLC, TB-500 5mg Spray is a specialized molecular tool for laboratories examining cellular mobility under controlled conditions.
TB-500 5mg Spray is a research-grade synthetic peptide solution developed for laboratory investigations involving cellular motility, tissue remodeling, and non-invasive delivery methods. Chemically classified as a synthetic analog of human Thymosin Beta-4, it comprises 43 amino acid residues with the sequence Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH, featuring an acetylated N-terminus. As an investigational compound, TB-500 is studied for its ability to bind monomeric G-actin and modulate actin dynamics.
From a molecular research perspective, TB-500 Spray provides a valuable model for investigating the transport kinetics of actin-modulating peptides across epithelial cell layers. Standard regenerative studies frequently depend on parenteral routes; however, liquid spray preparations enable researchers to evaluate how medium-sized hydrophilic peptides cross mucosal membranes, interact with tight junctions, and engage localized cellular receptors. This spray format is particularly suited for research involving nasal mucosal cell lines.
Current laboratory investigations examine TB-500's primary mechanism as a G-actin sequestering molecule. In eukaryotic cells, the actin cytoskeleton is a dynamic structure that undergoes continuous remodeling. TB-500 binds monomeric globular actin (G-actin) in a 1:1 stoichiometry, preventing its polymerization into filamentous actin (F-actin). This maintains a reserve pool of unpolymerized actin monomers, which is critical for cell locomotion, cytoskeletal polarization, and intracellular trafficking in migrating cells.
Beyond actin sequestration, researchers use TB-500 to explore angiogenesis and endothelial cell migration. Studies evaluate how exposure to the peptide upregulates matrix metalloproteinases (MMPs), facilitating extracellular matrix degradation and enabling endothelial cells to form capillary-like tube structures. This angiogenic cascade is studied to analyze tissue vascularization potential, collagen deposition, and cellular migration kinetics under controlled conditions.
In neurobiology and wound healing research, the intranasal spray format provides an optimized experimental model for studying direct mucosal absorption and localized tissue uptake. Researchers evaluate whether mucosal delivery facilitates direct transport of Thymosin Beta-4 analogs to injured tissues or local mucosal cell receptors. This allows the study of tissue remodeling, macrophage infiltration, and localized cellular migration without systemic variables.
Each bottle of TB-500 Spray is manufactured using solid-phase peptide synthesis (SPPS), followed by purification and solution formulation steps. The resulting active peptide is dissolved in a stabilized, buffered aqueous solution calibrated to ensure exact concentration per metered spray activation. Quality control protocols include reverse-phase high-performance liquid chromatography (HPLC) for purity verification and liquid chromatography-mass spectrometry (LC-MS) for molecular identity confirmation.
To preserve the stability of the peptide in solution, TB-500 Spray should be stored under refrigeration (2°C to 8°C) and protected from light. Because medium-sized peptides can undergo slow oxidation or peptide cleavage in aqueous environments over time, maintaining refrigerated storage and minimizing atmospheric exposure is critical to preserving peptide integrity. Proper handling supports consistent concentration and analytical reproducibility across laboratory protocols.
Scientific interest in TB-500 continues to expand as researchers seek to characterize its stability, actin interactions, and transport kinetics. Nevertheless, many aspects of its cellular signaling and epithelial transport remain active areas of scientific inquiry. Ongoing studies continue to refine the understanding of actin-sequestering peptides in biological systems. For this reason, TB-500 Spray should be regarded as an investigational compound whose primary value lies in advancing scientific knowledge of regenerative biology.
TB-500 Spray is supplied exclusively for laboratory research and analytical applications. It is intended for Research Use Only (RUO) and is not approved for human consumption, therapeutic use, veterinary use, or diagnostic purposes.

Telomerase enzyme explained: how TERT and TERC maintain telomeres, why it matters in aging and cancer research, plus RUO peptide sourcing. Read the guide.

KLOW peptide research blend is drawing attention across California's research community. Discover its composition, COA basics, and current evidence limits.

Learn what a peptide bond is, how it forms through dehydration synthesis, and why its structure matters for research peptides. Read the full guide now.
(faqs)